• Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

  • Slide

    Colorectal Cancer Europe Roundtable 2017

    11th April 2018, Brussels

Colorectal Cancer is the second most common cause of cancer death in the European Union, accounting for one in seven new cancers and one in eight cancer deaths.

In 2012, it was estimated that 241 600 European men were diagnosed with colorectal cancer, and that 113 200 men died from the disease. For European women, 205 200 cases of colorectal cancer and 101 500 related deaths were recorded that year.

Over the past two decades in Europe, early detection of colorectal cancer has increased through screening, as key to reduce the mortality rates from colorectal cancer. At the same time, new treatments have been developed and their availability improved.

The EU must raise greater awareness of CRC through educating, highlighting the risk factors and symptoms and promoting healthier lifestyles as a preventive measure.

This roundtable meeting will bring together; EU policy makers, medical and clinical professionals, academic experts, healthcare players and patient groups, to examine the ongoing challenges in managing CRC more effectively and explore practical solutions in order to reach an EU-wide consensus and implement a forward action plan.

Participants will benefit from the insights of EU health officials and leading oncology experts, offering a variety of perspectives and recommendations through a series of open discussions. 

Subjects to be addressed include:
  • Latest data surveillance and guidelines
  • Current policy, guidelines and schemes in the EU and Member States
  • Education and research opportunities and gaps
  • Chemotherapy, Immunotherapy, Targeted Therapy – overcoming key inhibitors
  • Identifying policy gaps in assessment, diagnosis, referral and follow-up
  • Quality of life for survivors and end of life care – where is the EU falling short?

Networking:

The Roundtable will also provide hours of networking time, including coffee breaks, lunch to ensure participants have the maximum possible time to establish and strengthen relationships, whilst exchanging ideas.